Finally, it is important to carry out a comprehensive analysis of additional metabolic parameters other than obesity, for instance, metabolic syndrome, insulin, c-peptide, blood glucose, etc. on patients’ outcomes (51–53), so as to provide a more precise view regarding patient metabolism and cancer survival. The gene discussed is INS; the disease is obesity disorder.